Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A.
Závada J, Sinikka Pesicková S, Rysavá R, Horák P, Hrncír Z, Lukác J, Rovensky J, Vítová J, Havrda M, Rychlík I, Böhmova J, Vlasáková V, Slatinská J, Zadrazil J, Olejárová M, Tegzova D, Tesar V. Závada J, et al. Among authors: bohmova j. Lupus. 2014;23(1):69-74. doi: 10.1177/0961203313511555. Epub 2013 Nov 8. Lupus. 2014. PMID: 24213308
Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.
Zavada J, Pesickova S, Rysava R, Olejarova M, Horák P, Hrncír Z, Rychlík I, Havrda M, Vítova J, Lukác J, Rovensky J, Tegzova D, Böhmova J, Zadrazil J, Hána J, Dostál C, Tesar V. Zavada J, et al. Among authors: bohmova j. Lupus. 2010 Oct;19(11):1281-9. doi: 10.1177/0961203310371155. Epub 2010 Jul 6. Lupus. 2010. PMID: 20605876 Clinical Trial.
The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period.
Pavelka K, Trc T, Karpas K, Vítek P, Sedlácková M, Vlasáková V, Böhmová J, Rovenský J. Pavelka K, et al. Among authors: bohmova j. Arthritis Rheum. 2007 Dec;56(12):4055-64. doi: 10.1002/art.23056. Arthritis Rheum. 2007. Retraction in: Arthritis Rheumatol. 2023 Aug;75(8):1497. doi: 10.1002/art.42546 PMID: 18050202 Free article. Retracted. Clinical Trial.
Delirious conditions in surgical ICU - case report.
Fulík J, Horák P, Picmausová I, Böhmová J, Vobořil R. Fulík J, et al. Among authors: bohmova j. Rozhl Chir. 2021 Winter;100(10):497-501. doi: 10.33699/PIS.2021.100.10.497-501. Rozhl Chir. 2021. PMID: 35021841 English.
Clinical Potential of Effective Noninvasive Exclusion of KEL1-Positive Fetuses in KEL1-Negative Pregnant Women.
Böhmova J, Vodicka R, Lubusky M, Holuskova I, Studnickova M, Kratochvilova R, Krejcirikova E, Janikova M, Durdová V, Dolezalová T, Filipová H, Dusek L, Dhaifalah I, Vomackova K, Kacerovsky M, Prochazka M, Vrtel R. Böhmova J, et al. Fetal Diagn Ther. 2016;40(1):48-53. doi: 10.1159/000441296. Epub 2015 Oct 23. Fetal Diagn Ther. 2016. PMID: 26492079
Risk Minimization of Hemolytic Disease of the Fetus and Newborn Using Droplet Digital PCR Method for Accurate Fetal Genotype Assessment of RHD, KEL, and RHCE from Cell-Free Fetal DNA of Maternal Plasma.
Vodicka R, Bohmova J, Holuskova I, Krejcirikova E, Prochazka M, Vrtel R. Vodicka R, et al. Among authors: bohmova j. Diagnostics (Basel). 2021 Apr 28;11(5):803. doi: 10.3390/diagnostics11050803. Diagnostics (Basel). 2021. PMID: 33925253 Free PMC article.
20 results